Evidence for cognitive impairment in mastocytosis: prevalence, features and correlations to depression.
Mastocytosis is a heterogeneous disease characterized by mast cells accumulation in one or more organs. We have reported that depression is frequent in mastocytosis, but although it was already described, little is known about the prevalence and features of cognitive impairment. Our objective was to...
Main Authors: | Daniela Silva Moura, Serge Sultan, Sophie Georgin-Lavialle, Stéphane Barete, Olivier Lortholary, Raphael Gaillard, Olivier Hermine |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22745762/pdf/?tool=EBI |
Similar Items
-
Depression in patients with mastocytosis: prevalence, features and effects of masitinib therapy.
by: Daniela Silva Moura, et al.
Published: (2011-01-01) -
Targeted Treatment Options in Mastocytosis
by: Mélanie Vaes, et al.
Published: (2017-07-01) -
Clinical potential of midostaurin in advanced systemic mastocytosis
by: Chandesris MO, et al.
Published: (2017-05-01) -
Case-control cohort study of patients' perceptions of disability in mastocytosis.
by: Olivier Hermine, et al.
Published: (2008-05-01) -
Phenotypic and genotypic characteristics of mastocytosis according to the age of onset.
by: Fanny Lanternier, et al.
Published: (2008-04-01)